Form 4: Chemed Corp Director Ron DeLyons Acquires Shares in Recent Transaction
SEC Form 4 Filing
Director Ron DeLyons acquired 284 shares of Chemed Corp capital stock at $564.34 per share on May 20, 2024.
Summary
- On May 20, 2024, Ron DeLyons, a director of Chemed Corp, acquired 284 shares of the company's capital stock.
- The acquisition price was $564.34 per share.
- Following the transaction, DeLyons directly owns 1,389 shares of Chemed Corp.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a routine transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date of transaction: Ron DeLyons acquired shares of Chemed Corp capital stock. |
| 05/21/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.